Healthcare Innovation MAK-SYSTEM specializes in developing advanced blood, plasma, and cellular products management technologies, providing opportunities to target healthcare providers seeking to modernize their biological supply chains with innovative solutions.
Strategic Partnerships Recent collaborations with prominent organizations like Northern Ireland Blood Transfusion Service and New York Blood Center highlight potential avenues for expanding into large blood service networks and establishing long-term enterprise relationships.
Cloud Platform Expansion The launch of MAK.care, a cloud-based blood and biologics management platform in collaboration with AWS, suggests growing demand for scalable, cloud-native solutions—an opportunity to offer complementary cloud or integration services.
Regulatory Expertise Participation in industry events like ISCT and AABB underscores MAK-SYSTEM's focus on regulated environments, indicating a market need for compliance-driven software solutions suitable for hospitals, labs, and biotech firms.
Financial Range With revenues between $25M and $50M, MAK-SYSTEM is an emerging player ripe for partnerships or sales expansion aimed at growing mid-sized healthcare tech companies and those looking to invest in blood management innovations.